Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study

Author:

Bravo Julio1,Baltasar Tello Patricia2,González Garcia Esther3,Ríos Herranz Eduardo4,Páyer Angel Ramirez5,Terol Castera María José6,Champ Diana7,Medina Perez Angeles8,Gironella Mercedes9,Fernández Zarzoso Miguel10,Forés Rafael11,Delgado Julio12,Garcia-Marco José A.1ORCID,Fernández Alicia Rodríguez13,Prat Ana Muntañola14,Cabrera Alexia Suárez15,Puerta Puerta José Manuel16,Rodríguez Mercedes17,Clavel Juana18,Dourdil Sahun Maria Victoria19,Coll Christelle Ferra20,Persona Ernesto Pérez21,Marrero Santos Carmen Milagros22,

Affiliation:

1. Molecular Cytogenetics Unit, Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain

2. Hematology Department, Hospital Universitario la Paz, Madrid, Spain

3. Hematology Department, Hospital Universitario de Cabueñes, Gijón, Spain

4. Hematology Department, Hospital Universitario Nuestra Señora de Valme, Sevilla, Spain

5. Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain

6. Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain

7. Roche Farma S.A, Madrid, Spain

8. Hematology Department, Hospital Costa del Sol, Marbella, Spain

9. Hematology Department, Hospital Universitario Vall d‘Hebron, Barcelona, Spain

10. Hematology Department, Hospital Universitario Dr Peset, Valencia, Spain

11. Flow Cytometry Unit, Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain

12. Hematology Department, Hospital Clínic, Barcelona, Spain

13. Hospital Universitario Virgen Macarena, Sevilla, Spain

14. Hospital Mutua de Terrasa, Barcelona, Spain

15. Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain

16. Hospital Universitario Virgen de las Nieves, Granada, Spain

17. Miguel Fernández Zarzoso, Hospital Universitario Dr. Peset, Valencia, Spain

18. Hospital de Navarra, Pamplona, Spain

19. Hospital General de Castellón, Castellón, Spain

20. Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain

21. Hospital Universitario German Trias i Pujol, Barcelona, Spain

22. Hospital de Txagorritxu, Vitoria, Spain

Funder

Roche Farma S.A

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3